HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Vervloet Selected Research

hemoglobin Amsterdam

1/2005Hb Amsterdam [alpha32(B13)Met--Ile (alpha2)]: a new unstable variant associated with an alpha-thalassemia phenotype and a new African polymorphism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Vervloet Research Topics

Disease

1Hypochromic Anemia (Chlorosis)
01/2005
1Hemoglobinopathies
01/2005
1alpha-Thalassemia
01/2005
1Renal Insufficiency (Renal Failure)
01/2005

Drug/Important Bio-Agent (IBA)

1hemoglobin AmsterdamIBA
01/2005
1CortisoneFDA Link
01/2005
1Ferritins (Ferritin)IBA
01/2005